BRD2 and infection: Panels included: spiked samples; NAT−/serology−, NAT+/serology+, and NAT−/serology+ blood donor samples; samples from persons with HIV (PWH) who started antiretroviral treatment (ART) at chronic infection stages; and from PWH under ART since acute/early infection.